You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
The post-debate debate
I know, no one wants to talk about the first 2024 presidential debate. But we’ve got post-debate polls, Democratic tension and real questions about where the race, and the conversation around health care policy, go from here. From “we finally beat Medicare,” to abortion rights, health programs’ solvency, and high drug prices, there was a surprising amount of health care debate Thursday night — but little of it substantive, or accurate.
The president stumbled explaining his two most popular campaign talking points: Protecting abortion rights and lowering prescription drug costs. Biden was garbled when explaining Roe’s framework and erred multiple times as he talked about landmark legislation to negotiate drug prices and cap insulin costs.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect